Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.

Arthritis research & therapy - 1 Jan 2007

Carroll Lisa, Frazer Ian H, Turner Malcolm, Marwick Thomas H, Thomas Ranjeny

Abstract excerpt

Patients with rheumatoid arthritis (RA) are at risk of excess mortality, predominantly owing to cardiovascular (CV) events. The receptor for advanced glycation end products (RAGE) has been implicated in the perpetuation of the chronic inflammatory response in vascular disease. A Gly82-->Ser polym...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Glycine
Share to HLA-DRB1 Chains

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipidemias

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Share to Serine

Source

Open in PubMed Open full text

Identifiers

PMID: 17425804
DOI: 10.1186/ar2175
PMCID: PMC1906817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17425804-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.PMID 17425804Read ↗

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response.Semantic proximity Read ↗

The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.Semantic proximity Read ↗

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene PolymorphismSemantic proximity Read ↗

Association of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.Semantic proximity Read ↗

Association of polymorphisms of the receptor for advanced glycation end products gene and susceptibility to sporadic abdominal aortic aneurysm.Semantic proximity Read ↗

Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis.Semantic proximity Read ↗

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.Semantic proximity Read ↗

The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.Semantic proximity Read ↗

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.Semantic proximity Read ↗

Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.Semantic proximity Read ↗

Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.Semantic proximity Read ↗

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.